104 related articles for article (PubMed ID: 8303591)
1. [Evaluation of the efficacy and tolerance of the new delayed-action angiotensin-converting enzyme inhibitor cilazapril in patients with hypertension (preliminary report)].
Vil'chinskaia MIu; Sorokin EV; Podinovskaia IaV; Karpov IuA
Ter Arkh; 1993; 65(9):32-4. PubMed ID: 8303591
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of cilazapril in patients with essential hypertension.
Karpov YA; Vilchinskaya MY; Sorokin EV; Podinovskaya VA
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S86-8. PubMed ID: 7700074
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of cilazapril in essential hypertensive patients. Clinical study with 24 h ambulatory blood pressure monitoring.
Hiwatari M; Abe K; Yoshinaga K; Saito T
Arzneimittelforschung; 1991 Nov; 41(11):1137-40. PubMed ID: 1839765
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure.
Nakanishi T; Takahashi H; Nishimura M; Yoshimura M
Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038
[TBL] [Abstract][Full Text] [Related]
6. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
7. [Cilazapril in the treatment of patients with arterial hypertension].
Talipova IZh; Zaslavskaia RM; Berkinbaev SF
Klin Med (Mosk); 2002; 80(8):50-2. PubMed ID: 12360621
[TBL] [Abstract][Full Text] [Related]
8. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
Abrahám G; Pogátsa-Murray G; Forster T; Csanády M; Sonkodi S
Orv Hetil; 1996 Jul; 137(29):1583-6. PubMed ID: 8757070
[TBL] [Abstract][Full Text] [Related]
9. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Waeber B; Weidmann P; Wohler D; Le Bloch Y
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
[TBL] [Abstract][Full Text] [Related]
10. Review of studies on the clinical pharmacodynamics of cilazapril.
Belz GG; Breithaupt K; Erb K
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
[TBL] [Abstract][Full Text] [Related]
11. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
12. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic experience with cilazapril.
Rosenthal JH
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S65-9. PubMed ID: 7898097
[TBL] [Abstract][Full Text] [Related]
14. [The Israeli trial with cilazapril (Vasocase) for the treatment of hypertension--summary of the care of 413 patients in a community health setting].
Zimlichman R
Harefuah; 2000 Mar; 138(5):345-50, 424. PubMed ID: 10883128
[TBL] [Abstract][Full Text] [Related]
15. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
16. [The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril].
Sabatini D; Fazio S; Cittadini A; Biondi B; Lucariello A; Picano T; Saccà L
Cardiologia; 1993 Jun; 38(6):377-81. PubMed ID: 8402747
[TBL] [Abstract][Full Text] [Related]
17. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
18. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
Mallion JM; Dutrey-Dupagne C; Vaur L; Genes N; Renault M; Elkik F; Baguet P; Boutelant S
J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487
[TBL] [Abstract][Full Text] [Related]
19. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of the efficacy and tolerance of delayed-action nifedipine as the monotherapy or in combination with metoprolol in patients with arterial hypertension].
Isaĭkina OIu; Gorbunov VM; Andreeva GF; Dmitrieva NA; Martsevich SIu
Ter Arkh; 2003; 75(12):39-43. PubMed ID: 14959468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
